New study tests Long-Term skin relief for psoriasis patients
NCT ID NCT07190391
Summary
This study aims to see how well and how safely the drug apremilast works for adults with moderate-to-severe psoriasis over 32 weeks. About 425 participants will take the drug and have their skin symptoms and quality of life checked at regular visits. The goal is to gather more real-world information on controlling this chronic skin condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.